167 related articles for article (PubMed ID: 38805059)
21. Family physicians and accutane.
Van Durme DJ
Am Fam Physician; 2000 Oct; 62(8):1772, 1774, 1777. PubMed ID: 11057835
[No Abstract] [Full Text] [Related]
22. Isotretinoin: update on controversial issues.
Prevost N; English JC
J Pediatr Adolesc Gynecol; 2013 Oct; 26(5):290-3. PubMed ID: 24147278
[TBL] [Abstract][Full Text] [Related]
23. A Call for Gender Identity Data Collection in iPLEDGE and Increasing the Number of Isotretinoin Prescribers Among Transgender Health Providers.
Singer S; Keuroghlian AS
LGBT Health; 2020 Jul; 7(5):216-219. PubMed ID: 32456537
[TBL] [Abstract][Full Text] [Related]
24. Gender disparities in isotretinoin prescribing patterns for pediatric patients before and during practice changes introduced by the COVID-19 pandemic.
Tan AJ; Xia J; Herringshaw E; Mayur O; Iqbal A; Cucka B; Biglione B; Locascio JJ; Kroshinsky D
Pediatr Dermatol; 2023; 40(5):869-872. PubMed ID: 37495565
[TBL] [Abstract][Full Text] [Related]
25. Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey.
Landis ET; Levender MM; Davis SA; Feneran AN; Gerancher KR; Feldman SR
J Dermatolog Treat; 2012 Aug; 23(4):272-7. PubMed ID: 22380867
[TBL] [Abstract][Full Text] [Related]
26. The Burden of iPLEDGE Requirements on Dermatologists: A Survey Study.
Owens KE; Jiang SW; Liu WW; Nicholas MW
Arch Dermatol Res; 2024 May; 316(6):305. PubMed ID: 38819442
[No Abstract] [Full Text] [Related]
27. Isotretinoin Monitoring Trends: A National Survey of Dermatologists.
Hobson JG; Cunningham MJ; Lesiak K; Lester EB; Tegeder AR; Zeeck E; Hugh JM; Lin JH
J Drugs Dermatol; 2017 Jun; 16(6):557-564. PubMed ID: 28686773
[TBL] [Abstract][Full Text] [Related]
28. Depression screening using health questionnaires in patients receiving oral isotretinoin for acne vulgaris.
Schrom K; Nagy T; Mostow E
J Am Acad Dermatol; 2016 Jul; 75(1):237-9. PubMed ID: 27317530
[TBL] [Abstract][Full Text] [Related]
29. The use of oral vitamin A in acne management: a review.
Cook MK; Perche PO; Feldman SR
Dermatol Online J; 2022 Oct; 28(5):. PubMed ID: 36809126
[TBL] [Abstract][Full Text] [Related]
30. Readability of iPledge materials for isotretinoin education in English and Spanish.
DeMeo D; Reddy HA; Cowden MP; Maytin AK; Carroll BT
Arch Dermatol Res; 2023 Sep; 315(7):2175-2178. PubMed ID: 36918437
[TBL] [Abstract][Full Text] [Related]
31. A pox on your practice. iPLEDGE program scars dermatologists.
Ortolon K
Tex Med; 2006 May; 102(5):29-31. PubMed ID: 17115578
[No Abstract] [Full Text] [Related]
32. A comparative review of the isotretinoin pregnancy risk management programs across four continents.
Kovitwanichkanont T; Driscoll T
Int J Dermatol; 2018 Sep; 57(9):1035-1046. PubMed ID: 29508918
[TBL] [Abstract][Full Text] [Related]
33. The Importance of Gender-Neutral Terminology in Risk Evaluation and Mitigation Strategy Programs: A Call to Action.
Burnette C; Smithy W; Strock D; Sivesind TE; Dellavalle R
JMIR Dermatol; 2023 Jun; 6():e45329. PubMed ID: 37632908
[TBL] [Abstract][Full Text] [Related]
34. Contradictory iPledge Requirements Hinder Physician Practice and Patient Care.
Pousti BT; Mollanazar NK
JAMA Dermatol; 2020 Feb; 156(2):222. PubMed ID: 31895417
[No Abstract] [Full Text] [Related]
35. Contradictory iPledge Requirements Hinder Physician Practice and Patient Care-Reply.
Tkachenko E; Singer S; Mostaghimi A
JAMA Dermatol; 2020 Feb; 156(2):222-223. PubMed ID: 31895435
[No Abstract] [Full Text] [Related]
36. Emergency contraception in the iPLEDGE program: A cross-sectional survey of pediatric dermatology provider understanding and practice.
Smiley CE; Butt M; Zaenglein AL
Pediatr Dermatol; 2022 Sep; 39(5):727-730. PubMed ID: 35918308
[TBL] [Abstract][Full Text] [Related]
37. US Food and Drug Administration Reports of Pregnancy and Pregnancy-Related Adverse Events Associated With Isotretinoin.
Tkachenko E; Singer S; Sharma P; Barbieri J; Mostaghimi A
JAMA Dermatol; 2019 Oct; 155(10):1175-1179. PubMed ID: 31314041
[TBL] [Abstract][Full Text] [Related]
38. Are there racial and sex differences in the use of oral isotretinoin for acne management in the United States?
Fleischer AB; Simpson JK; McMichael A; Feldman SR
J Am Acad Dermatol; 2003 Oct; 49(4):662-6. PubMed ID: 14512913
[TBL] [Abstract][Full Text] [Related]
39. Isotretinoin and iPledge Program patient information video: A new modality that improves patient comprehension.
Greywal T; Eichenfield LF; Marsch A
J Am Acad Dermatol; 2021 May; 84(5):1425-1426. PubMed ID: 32565207
[No Abstract] [Full Text] [Related]
40. Exploring the costs associated with isotretinoin treatment.
Shah N; Byrne M; Kirkorian AY
Pediatr Dermatol; 2021 Sep; 38(5):1396-1399. PubMed ID: 34463375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
